| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025679A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 12/23/1993 | WO1993025673A1 In vivo gene therapy with intron-free sequence of interest |
| 12/23/1993 | WO1993025666A1 Recombinant entomopoxvirus |
| 12/23/1993 | WO1993025567A1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 12/23/1993 | WO1993025566A1 Deuterated nucleosides |
| 12/23/1993 | WO1993025563A1 A method of detecting and discriminating between nucleic acid sequences |
| 12/23/1993 | WO1993025234A1 Methods and compositions for targeting specific tissue |
| 12/23/1993 | WO1993025210A1 Diphtheria toxin vaccines |
| 12/23/1993 | WO1993022434A3 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 12/23/1993 | CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use |
| 12/23/1993 | CA2137449A1 Recombinant entomopoxvirus |
| 12/22/1993 | EP0380559B1 Oligonucleotide functionalizing reagents and methods |
| 12/22/1993 | CN1079749A Toxins |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/21/1993 | US5272250 Boronated phosphoramidate compounds |
| 12/21/1993 | US5272077 Method for preparing a covalent conjugate of an oligonucleotide and an enzyme |
| 12/21/1993 | US5272065 Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
| 12/15/1993 | EP0574347A2 Novel fungal protease |
| 12/15/1993 | EP0574029A1 Recombinant DNA molecules |
| 12/15/1993 | EP0573564A1 Nestin expression as an indicator of neuroepithelial tumors |
| 12/15/1993 | EP0227795B1 Method for performing nucleic acid hybridization assays |
| 12/14/1993 | US5270163 Methods for identifying nucleic acid ligands |
| 12/09/1993 | WO1993024659A1 Methods and pharmaceutical kits useful for detecting microorganisms associated with vaginal infections |
| 12/09/1993 | WO1993024657A2 Use of genetic markers to diagnose familial dysautonomia |
| 12/09/1993 | WO1993024656A1 Ligase chain reaction starting with rna sequences |
| 12/09/1993 | WO1993024640A2 Methods and compositions for in vivo gene therapy |
| 12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
| 12/09/1993 | WO1993024512A1 Nucleic acid homologue |
| 12/09/1993 | WO1993024511A1 Oligonucleotide-polyamide conjugates |
| 12/09/1993 | WO1993024510A1 Phosphotriester-type biologically active compounds |
| 12/09/1993 | WO1993024508A1 Binding competent oligomers containing 2', 5' linkages |
| 12/09/1993 | WO1993024507A1 Conformationally restrained oligomers containing amide or carbamate linkages for sequence-specific binding |
| 12/09/1993 | WO1993024133A1 CHIMERIC tRNALYS-RIBOZYME MOLECULES |
| 12/09/1993 | WO1993024055A1 Method of quantitative determination of bone salt with ct equipment |
| 12/09/1993 | WO1993022459A3 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum |
| 12/09/1993 | CA2136857A1 Cryptosporidium polypeptides, nucleic acid, vectors and methods of use |
| 12/09/1993 | CA2136764A1 Ligase chain reaction starting with rna sequences |
| 12/09/1993 | CA2134773A1 Methods and compositions for in vivo gene therapy |
| 12/09/1993 | CA2114312A1 Chimeric trnalys-ribozyme molecules |
| 12/08/1993 | EP0572907A2 Chemically synthesized silanes that bind nucleic acids |
| 12/08/1993 | EP0572529A1 Aptamer specific for biomolecules and method of making |
| 12/08/1993 | EP0554355A4 Mehods and pharmaceutical kits useful for detecting microorganisms associated with vaginal infections |
| 12/08/1993 | EP0267204B1 Immunopotentiation |
| 12/08/1993 | EP0131052B1 Method for detecting, identifying, and quantitating organisms and viruses |
| 12/07/1993 | US5268464 Process for the preparation of nucleosides |
| 12/07/1993 | US5268268 Treating with a primer |
| 12/02/1993 | CA2096193A1 Chemically synthesized silanes that bind nucleic acids |
| 12/01/1993 | EP0572287A2 Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression |
| 12/01/1993 | EP0572120A1 Nucleic acid probes to mycobacterium tuberculosis |
| 12/01/1993 | EP0571911A2 Mycobacteria probes |
| 12/01/1993 | EP0571538A1 Structural gene of pneumococcal protein |
| 12/01/1993 | EP0395731A4 Oligonucleotide probes for detection of periodontal pathogens |
| 11/27/1993 | CA2096497A1 Mycobacteria probes |
| 11/25/1993 | WO1993023570A1 Oligonucleotides having conjugates attached at the 2'-position of the sugar moiety |
| 11/25/1993 | WO1993023569A1 Method and reagent for inhibiting viral replication |
| 11/25/1993 | WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/25/1993 | WO1993023541A1 Hepatocyte growth factor variants |
| 11/25/1993 | WO1993023431A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 11/25/1993 | WO1993023429A1 Receptor-type tyrosine kinase-like molecules |
| 11/25/1993 | WO1993023423A1 Canine coronavirus s gene and uses therefor |
| 11/25/1993 | WO1993023422A1 Compositions and methods for vaccination against coronaviruses |
| 11/25/1993 | WO1993023421A1 Universal coronavirus vaccine |
| 11/25/1993 | WO1993023068A1 Platelet derived growth factor antagonists |
| 11/25/1993 | WO1993023057A1 Method and reagent for inhibiting cancer development |
| 11/25/1993 | CA2135749A1 Platelet derived growth factor antagonists |
| 11/25/1993 | CA2135646A1 Method and reagent for inhibiting viral replication |
| 11/25/1993 | CA2135499A1 Method and reagent for inhibiting cancer development |
| 11/25/1993 | CA2135471A1 Receptor-type tyrosine kinase-like molecules |
| 11/25/1993 | CA2135201A1 Universal coronavirus vaccine |
| 11/25/1993 | CA2134898A1 Compositions and methods for vaccination against coronaviruses |
| 11/25/1993 | CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/25/1993 | CA2118012A1 Hepatocyte growth factor variants |
| 11/24/1993 | EP0571087A1 Cleavable phosphoramidites |
| 11/24/1993 | EP0570518A1 Methods and apparatus for improved electrochemi luminescence assays |
| 11/24/1993 | EP0570514A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom |
| 11/23/1993 | US5264566 Method for in vitro oligonucleotide synthesis using H-phosphonates |
| 11/23/1993 | US5264564 Oligonucleotide analogs with novel linkages |
| 11/23/1993 | US5264563 Sequentially coupling monomers on supports to form atleast two tuplet sin separate reaction vessels, mixing and into two or more reaction vessels, repeating the process |
| 11/23/1993 | US5264562 Oligonucleotide analogs with novel linkages |
| 11/23/1993 | US5264558 Single-chain monellin analog as a low calorie protein sweetner |
| 11/23/1993 | US5264554 Platelet cell adhesion molecule and variants thereof |
| 11/23/1993 | US5264423 Phosphorothioate, methyl phosphonate, phosphorotriester and phosphodiester oligodeoxyribonucleotide analogs; antitumor agents |
| 11/23/1993 | US5264101 Using a tube having surface-charged inner walls and filled with an electrolyte having an opposite charge |
| 11/18/1993 | EP0570027A1 T cell receptor-specific for antigen polypeptides and related polynucleotides |
| 11/18/1993 | EP0448609B1 In vitro mutagenesis |
| 11/17/1993 | CN1078473A "Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof" |
| 11/16/1993 | US5262536 Reagents for the preparation of 5'-tagged oligonucleotides |
| 11/16/1993 | US5262530 Solid phase synthesis on polystyrene support, phosphoramidite chemistry |
| 11/16/1993 | US5262170 DNA sequences and proenzymes |
| 11/11/1993 | WO1993022680A1 Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
| 11/11/1993 | WO1993022665A1 Capillary electrophoresis molecular weight separation of biomolecules using a polymer-containing solution |
| 11/11/1993 | WO1993022480A1 Electrochemical treatment of surfaces |
| 11/11/1993 | WO1993022461A1 Nucleic acid sequence amplification method, composition and kit |
| 11/11/1993 | WO1993022459A2 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum |
| 11/11/1993 | WO1993022458A1 A predictive assay for suicidal behavior |
| 11/11/1993 | WO1993022449A1 Inhibitory factor |
| 11/11/1993 | WO1993022434A2 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 11/11/1993 | WO1993022431A1 Constitutive and inducible epidermal vector systems |
| 11/11/1993 | WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals |